Author

Edana Cassol

Carleton UniversityORCID 0000-0002-8359-2739Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Research Focus:protein design· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Ashkan GolshaniiD· 2 shared Duale AhmediD· 2 shared Alex Edwards· 1 shared Alex WongiD· 1 shared Alfonso B. AbizaidiD· 1 shared Allan HumphreyiD· 1 shared Allison F. Jaworski· 1 shared Andrew LowiD· 1 shared

Activity by Year

2017-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ashkan GolshaniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 5, 2025

Nucleic acid strand length governs mitochondrial reprogramming and mtROS-associated antiviral responses following TLR3 engagement

Duale Ahmed, Malak Al Daraawi, Allan Humphrey…·Edana Cassol

This study shows that mitochondrial reprogramming and mtROS production differ based on the length of nucleic acid ligands engaged by TLR3, affecting antiviral responses in macrophages.

1 citation

mouseproteomics

𝕏 PostBluesky

Synthetic BiologyComputational Biology and ChemistryPeer-reviewedNov 2, 2017

Designing Anti-Zika Virus Peptides Derived from Predicted Human-Zika Virus Protein-Protein Interactions

Thomas David Daniel Kazmirchuk, Kevin Dick, Daniel. J. Burnside…·Ashkan Golshani

This study predicts human-Zika virus protein-protein interactions and designs synthetic peptides to disrupt these interactions as potential anti-Zika virus therapeutics.

28 citationstop 5%

virusprotein sequence

𝕏 PostBluesky